Viking Therapeutics (VKTX 1.70%) is developing VK2735, a dual GLP-1/GIP receptor agonist for obesity treatment. The company ...

As the world experiences accelerated change in technology and consumer preferences, the South African automotive industry has to embrace profound transformation to maintain its heritage of ...